patent/EP-3360881-A1

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3360881-A1

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_adc048c2a637cc5389e0118ca5b5f27a
classificationCPCAdditional	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J31-006 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J71-001
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J41-0061 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J71-001 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J9-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J31-006
classificationIPCAdditional	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J71-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J31-00
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J41-00
filingDate	2014-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0c8d1837e04d118927b0153c77add10
publicationDate	2018-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	EP-3360881-A1
titleOfInvention	11-hydroxyl-6-substituted-derivatives of bile acids and amino acid conjugates thereof as farnesoid x receptor modulators
abstract	The present invention provides a compound of formula (I): nor a pharmaceutically acceptable salt, solvate, or amino acid conjugate thereof, wherein R 1 is a hydroxy group and R 2 , R 3 , R 4 , R 5 , and R 6 are as described herein. The present invention relates generally to selective FXR agonists and to methods of making and using them.
priorityDate	2013-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2802775-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004007521-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1568706-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0037077-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0124903-A1
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID141830205 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465760353 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468146323 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468146318

Total number of triples: 37.